Oncogenic driver mutations in genes commonly associated with HNSCC, like P53, PI3-AKT pathway, HRAS, CCND1 and others, have been associated with poor survival and have been identified as important factors for outcome predictions in HNSCC cohorts (4, 8). This evidence concerns the gene CCND1 and head and neck squamous cell carcinoma.